VICTORY CAPITAL MANAGEMENT INC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,586
-63.0%
10,182
-0.4%
0.00%
Q1 2023$58,300
-99.2%
10,228
-98.7%
0.00%
-100.0%
Q4 2022$7,666,402
-65.1%
759,802
-22.5%
0.01%
-65.4%
Q3 2022$21,983,000
-17.4%
980,939
-8.6%
0.03%
-13.3%
Q2 2022$26,608,000
-32.7%
1,073,793
+5.0%
0.03%
-25.0%
Q1 2022$39,535,000
-29.3%
1,022,707
+7.1%
0.04%
-21.6%
Q4 2021$55,895,000
+3.4%
955,312
+4.7%
0.05%
-3.8%
Q3 2021$54,065,000
-52.6%
912,180
-30.7%
0.05%
-51.8%
Q2 2021$114,181,000
+4.4%
1,315,601
-0.9%
0.11%
-1.8%
Q1 2021$109,406,000
-31.3%
1,326,945
-24.2%
0.11%
-36.7%
Q4 2020$159,260,000
+63.7%
1,751,455
-28.1%
0.18%
+41.6%
Q3 2020$97,304,000
+10.6%
2,434,423
-5.0%
0.12%
+5.0%
Q2 2020$87,946,000
-43.0%
2,563,271
-63.1%
0.12%
-8.5%
Q1 2020$154,332,000
+86.5%
6,948,736
+64.3%
0.13%
+30.0%
Q4 2019$82,764,000
+45.7%
4,229,154
+15.6%
0.10%
+37.0%
Q3 2019$56,798,000
-4.4%
3,657,320
+24.9%
0.07%
-39.2%
Q2 2019$59,437,000
+71.4%
2,927,930
+48.3%
0.12%
+51.9%
Q1 2019$34,686,000
+105.0%
1,974,174
+49.7%
0.08%
+88.1%
Q4 2018$16,921,000
+97.0%
1,318,860
+150.1%
0.04%
+133.3%
Q3 2018$8,590,000
+47.2%
527,320
+2.5%
0.02%
+50.0%
Q2 2018$5,834,000
+4.0%
514,480
-10.5%
0.01%0.0%
Q1 2018$5,611,000
+174.4%
574,890
+71.8%
0.01%
+200.0%
Q4 2017$2,045,000
+457.2%
334,680
+260.7%
0.00%
+300.0%
Q3 2017$367,00092,7900.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders